2020
DOI: 10.1016/j.jadohealth.2019.11.306
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and Health Characteristics of Prescription Opioid Use, Misuse, and Use Disorders Among U.S. Adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
23
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(25 citation statements)
references
References 29 publications
2
23
0
Order By: Relevance
“…Socio-economic class as an influencing factor in substance use disorders is also worthy of discussion here. While the protagonists in our text set are middle class or affluent, Carmona et al, ( 2020 ) found that prescription opioid misuse and disorders were distributed almost evenly across socioeconomic strata with the Substance Abuse and Mental Health Services Administration reporting the same findings in a similar study. In other words, affluent white teen girls are not the only adolescents misusing substances.…”
Section: Implications: Why Does This Matter For Scholars and Readers?mentioning
confidence: 51%
See 2 more Smart Citations
“…Socio-economic class as an influencing factor in substance use disorders is also worthy of discussion here. While the protagonists in our text set are middle class or affluent, Carmona et al, ( 2020 ) found that prescription opioid misuse and disorders were distributed almost evenly across socioeconomic strata with the Substance Abuse and Mental Health Services Administration reporting the same findings in a similar study. In other words, affluent white teen girls are not the only adolescents misusing substances.…”
Section: Implications: Why Does This Matter For Scholars and Readers?mentioning
confidence: 51%
“…Further, males are more likely to experience substance use disorders when broadly defined (Gray & Squeglia, 2018 ; SAMHSA, 2019 ); the majority of protagonists across our text set are female. In a study of prescription opioid use and misuse, female adolescents had a higher incidence of prescription opioid use disorder than males by a slight margin (50.94 to 49.06%) (Carmona et al, 2020 ), but even that slightly higher incidence does not align with the overwhelming appearance of female protagonists across our texts. In the Substance Abuse and Mental Health Services Administration’s 2019 report, rates of occurrence of substance use disorders were roughly the same across racial and ethnic categories, with the exception of American Indian and Alaska Native (AIAN) adolescents, who experienced substance use disorders at nearly twice the rate of their white counterparts.…”
Section: Implications: Why Does This Matter For Scholars and Readers?mentioning
confidence: 66%
See 1 more Smart Citation
“…9 Our findings that Black and urban children were less likely than their counterparts to fill opioid prescriptions or experience adverse events, but more likely to experience other opioid-related harms (for example, abuse and dependence), increase the call for future studies to explore racial and geographic opioid-related inequities in children. 3,7,8,13 We identified preceding opioid prescription fills in almost 50 percent of adverse events, which may suggest a temporal relationship between children's own prescriptions and subsequent harms. In a 1999-2014 study in Tennessee, 89 percent of chart-adjudicated opioid adverse events were linked to children's prescriptions.…”
Section: Discussionmentioning
confidence: 94%
“…6 Disparities in pediatric opioid exposures and opioid-related harms have been reported by age, race, urban/ rural status, and medical complexity. 3,[6][7][8][9] In this study, we characterize age-stratified opioid exposures, opioid-related harms, and disparities for North Carolina Medicaid-insured children. As shown in exhibit 1, we found that the yearly prevalence of exposures and harms among children was highest among older adolescents, with one in ten (10.8 percent) adolescents ages 15-17 filling at least one opioid…”
mentioning
confidence: 99%